ArticleCureus2025
Ballantyne Syndrome Related to Down Syndrome and Chorioamnionitis: A Case Report and Literature Review.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ballantyne syndrome is a rare obstetric condition characterized by fetal hydrops, maternal edema, and placentomegaly. Its low incidence, combined with potential clinical overlap with preeclampsia, poses significant diagnostic and management challenges. This condition is especially relevant due to the severe complications it can cause during pregnancy. In this article, we present a case of Ballantyne syndrome associated with Down syndrome (DS) and chorioamnionitis, complemented by a literature review exploring its possible etiologies, pathophysiology, and therapeutic options. Additionally, the importance of early diagnosis, the use of invasive techniques to identify underlying etiologies, and therapeutic decision-making focused on safeguarding maternal life are emphasized, including pregnancy termination in cases of severe complications to optimize maternal and fetal outcomes.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.